Anatara Lifesciences (ASX:ANR) Total Liabilities : A$0.16 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Total Liabilities?

Anatara Lifesciences's Total Liabilities for the quarter that ended in Dec. 2023 was A$0.16 Mil.

Anatara Lifesciences's quarterly Total Liabilities increased from Dec. 2022 (A$0.24 Mil) to Jun. 2023 (A$0.50 Mil) but then declined from Jun. 2023 (A$0.50 Mil) to Dec. 2023 (A$0.16 Mil).

Anatara Lifesciences's annual Total Liabilities declined from Jun. 2021 (A$0.50 Mil) to Jun. 2022 (A$0.40 Mil) but then increased from Jun. 2022 (A$0.40 Mil) to Jun. 2023 (A$0.50 Mil).

Anatara Lifesciences Total Liabilities Historical Data

The historical data trend for Anatara Lifesciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Total Liabilities Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

0.47

0.49

0.50

0.40

0.50

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial														0.48	0.40	0.24	0.50	0.16

Anatara Lifesciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Anatara Lifesciences's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.494	+	(0	+	8.673617379884E-19
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.001)
	=	0.50

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	1.419	-	0.925
	=	0.49

Anatara Lifesciences's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.161	+	(0	+	0.002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.16

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	1.431	-	1.268
	=	0.16

Anatara Lifesciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines